Sign In
Buy BAX
$27.78
+0.230 (+0.83%)
At Close: Aug 10, 2026
Will Baxter's Q2 Results Continue to Reflect Operational Headwinds?
12:25pm, Friday, 24'th Jul 2026
BAX's second-quarter results may reflect pressured earnings and sales as manufacturing inefficiencies, inflation, and product holds offset steady demand across segments.
Earnings Preview: Baxter International (BAX) Q2 Earnings Expected to Decline
11:02am, Thursday, 23'rd Jul 2026
Baxter (BAX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AbbVie vs Baxter: One Golden Cross Is Real, One Is a Trap
07:45am, Wednesday, 15'th Jul 2026
Both AbbVie (NYSE:ABBV | ABBV Price Prediction) and Baxter International (NYSE:BAX) flashed the same technical signal this month: a golden cross, where the 50-day moving average pushed above the 200-d
Baxter to Host Second-Quarter 2026 Financial Results Conference Call for Investors
04:10pm, Thursday, 09'th Jul 2026
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medtech company, will host a conference call to discuss its second-quarter 2026 financial results on Thursday,
Baxter Publishes 2025 Sustainability Report Highlighting Refreshed Strategy, Ongoing Commitment to Drive Meaningful Impact
10:00am, Monday, 22'nd Jun 2026
Baxter International Inc. (NYSE: BAX), a global medtech leader, today published its newly renamed [url="]2025 Sustainability Report[/url], highlighting the comp
Baxter Publishes 2025 Sustainability Report Highlighting Refreshed Strategy, Ongoing Commitment to Drive Meaningful Impact
09:00am, Monday, 22'nd Jun 2026
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today published its newly renamed 2025 Sustainability Report, highlighting the company's progress and r
Baxter's Unit Synovis MCA to Lead Global Rollout of the SHIYA Platform
11:25am, Friday, 19'th Jun 2026
BAX gains as Synovis MCA signs a multi-year deal to commercialize MediThinQ's SHIYA 3D surgical visualization platform worldwide.
Reasons to Retain Baxter International Stock in Your Portfolio for Now
03:16pm, Tuesday, 16'th Jun 2026
BAX is pursuing a broad turnaround as innovation, resilient demand, and AI integration support recovery despite regulatory risks and margin pressure.
Baxter International Inc. (BAX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
02:42pm, Tuesday, 09'th Jun 2026
Baxter International Inc. (BAX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Baxter International Inc. (BAX) Presents at Bank of America Global Healthcare Conference 2026 Transcript
04:40pm, Wednesday, 13'th May 2026
Baxter International Inc. (BAX) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Baxter International Shareholders Approve Board Slate, Pay and Incentive Plan at Annual Meeting
09:06pm, Saturday, 09'th May 2026
Baxter International NYSE: BAX held its 2026 annual meeting of stockholders by webcast, with shareholders giving preliminary approval to all five proposals presented by the company, including the elec
Baxter International Still Has A Path To Upside
10:30pm, Thursday, 07'th May 2026
In recent years, stocks like Baxter International have underperformed: most low-growth, high-debt, struggling names have been bad investments at basically any price. Concerns are real, and early misst
Madison Small Cap Fund Q1 2026 Portfolio Activity
10:35pm, Monday, 04'th May 2026
ICU Medical's new high-volume pump has more connected features, which we believe will drive retention rates and incremental revenue. SiteOne Landscape Supply controls 18% of this $26 billion industry
Baxter International Inc. (BAX) Q1 2026 Earnings Call Transcript
03:51pm, Thursday, 30'th Apr 2026
Baxter International Inc. (BAX) Q1 2026 Earnings Call Transcript
BAX Stock Gains on Q1 Earnings & Sales Beat, Margins Contract
11:45am, Thursday, 30'th Apr 2026
Baxter beats Q1 earnings and revenue estimates, sending shares higher despite declining profits and margin contraction.
